Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B

International Journal of Oncology

Volumn 33, Issue 3, 2008, Pages 477-484

  Joung, Youn Hee ^a   Lim, Eun Joung ^a   Kim, Mi Sun ^a   Lim, So Dug ^b   Yoon, So Young ^b   Lim, Young Chang ^b   Yoo, Young Bum ^b   Ye, Sang Kyu ^c   Park, Taekyu ^a   Chung, Ill Min ^d   Bae, Ki Yeol ^d   Yang, Young Mok ^a  

^a Konkuk University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Konkuk University   (South Korea)

Author keywords

Aptosis; Human breast cancer cells; Hypoxia; Momilactone B; STAT5b

Indexed keywords

ANNEXIN; CASPASE; CHEMICAL COMPOUND; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; FLUORESCEIN ISOTHIOCYANATE; MOMILACTONE B; PROTEIN BAX; PROTEIN P21; SMALL INTERFERING RNA; STAT5 PROTEIN; STAT5B PROTEIN; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DITERPENE; LACTONE; PROTEIN BCL 2; STAT5B PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPOXIA; HYPOXIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; BREAST TUMOR; CELL HYPOXIA; CELL PROLIFERATION; DRUG EFFECT; FEMALE; GEL MOBILITY SHIFT ASSAY; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DITERPENES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; LACTONES; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; STAT5 TRANSCRIPTION FACTOR;

EID: 54849187900     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000030     Document Type: Article

References (39)

1. Pouyssegur J, Dayan F and Mazure NM: Hypoxia signaling in cancer and approaches to enforce tumor regression. Nature 441: 437-443, 2006.
2. Joung YH, Lim EJ, Lee MY, Park JH, Ye SK, Park EU, Kim SY, Zhang Z, Lee KJ, Park DK, Park TK, Moon WK and Yang YM: Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells. Exp Mol Med 37: 353-364, 2005.
3. Schmaltz C, Hardenbergh PH, Wells A and Fisher DE: Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol 18: 2845-2854, 1998.
4. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91, 1996.
5. Vaupel P, Kelleher DK and Hockel M: Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 28: 29-35, 2001.
6. Pettersen EO, Juul NO and Ronning OW: Regulation of protein metabolism of human cells during and after acute hypoxia. Cancer Res 46: 4346-4351, 1986.
7. Shih SC and Claffey KP: Hypoxia-mediated regulation of gene expression in mammalian cells. Int J Exp Pathol 79: 347-357, 1998.
8. Joung YH, Park JH, Park TK, Lee CS, Kim OH, Ye SK, Yang UM, Lee KJ and Yang YM: Hypoxia activates signal transducers and activators of transcription 5 (STAT5) and increases its binding activity to the GAS element in mammary epithelial cells. Exp Mol Med 35: 350-357, 2003.
9. Joung YH, Lee MY, Lim EJ, Kim MS, Hwang TS, Kim SY, Kim SY, Ye SK, Lee JD, Park TK, Woo YS, Chung IM and Yang YM: Hypoxia activates the IGF-1 expression through STAT5b in human HepG2 cells. Biochem Biophys Res Commun 358: 733-738, 2007.
10. Lee MY, Joung YH, Lim EJ, Park JH, Ye SK, Park TK, Zhang Z, Park DK, Lee KJ and Yang YM: Phosphorylation and activation of STAT proteins by hypoxia in breast cancer cells. Breast 15: 187-195, 2006.
11. Chin YE, Kitagawa M, Kuida K, Flavell RA and Fu XY: Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 17: 5328-5337, 1997.
12. Dudley AC, Thomas D, Best J and Jenkins A: A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia. Biochem J 390: 427-436, 2005.
13. Yamashita H, Nishio M, Fujii Y and Iwase H: Dominant-negative Stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude mice. Cancer Sci 95: 662-665, 2004.
14. Mo H and Elson CE: Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J Nutr 129: 804-813, 1999.
15. Behrens P, Brinkmann U and Wellmann A: CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis 8: 39-44, 2003.
16. Sun J and Liu RH: Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett 241: 124-134, 2006.
17. Kim SJ, Park HR, Park EJ and Lee SC: Cytotoxic and antitumor activity of Momilactone B from rice hulls. J Agric Food Chem 55: 1702-1706, 2007.
18. Tseng TH, Tsheng YM and Lee YJ: Cytotoxicity effects of di- and tri-hydroxybenzaldehydes as a chemopreventive potential agent on tumor cells. Toxicology 161: 179-187, 2001.
19. Semenza GL: Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med 54: 17-28, 2003.
20. More A, Cruz JM, Franco D, Domiguez JM, Sineiro J, Dominguez H, Nunez MJ and Parajo JC: Natural antioxidants from residual sources. Food Chem 72: 145-171, 2001.
21. Kalapathy U, Proctor A and Shultz J: Silicate thermal insulation material from rice hull ash. Ind Eng Chem Res 42: 46-49, 2003.
22. Hisashi KN and Takeshi I: Rice seedling release momilactone B into the environment. Phytochemistry 63: 551-554, 2003.
23. Chung IM, Kim JT and Kim SH: Evaluation of allelopathic potential and quantification of Momilactone A,B from rice hull extracts and assessment of inhibitory bioactivity on paddy field weeds. J Agric Food Chem 54: 2527-2536, 2006.
24. Bromberg J: Stat proteins and oncogenesis. J Clin Invest 109: 1139-1142, 2002.
25. Battle TE and Frank DA: The role of STATs in apoptosis. Curr Mol Med 2: 381-392, 2002.
26. Buettner R, Mora LB and Jove R: Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8: 945-954, 2002.
27. Sherr CJ and Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999.
28. Koziczak M, Holbro T and Hynes NE: Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins. Oncogene 23: 3501-3508, 2004.
29. Yamamoto K, Morishita R, Hayashi S, Matsushita H, Nakagami H, Moriguchi A, Matsumoto K, Nakmura T, Kaneda Y and Ogihara T: Contribution of bcl-2, but not bcl-xL and bax, to antiapoptotic actions of hepatocyte growth factor in hypoxia-conditioned human endothetial cells. Hypertension 37: 1341-1348, 2001.
30. Harrison-Shostak DC, Lemasters JJ, Edgell CJ and Herman B: Role of ICE-like pretease in endothelial cell hypoxic and reperfusion injury. Biochem Biophys Res Commun 231: 844-847, 1997.
31. Muschel RJ., Bernhard EJ, Garza L, McKenna WG and Koch CJ: Induction of apoptosis at different oxygen tensions: evidence that oxygen radicals do not mediate apoptotic signaling. Cancer Res 55: 995-998, 1995.
32. Thornberry N and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998.
33. Yang YP, Kuo HS, Tsai HD, Peng YC and Lin YL: The p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinyl-naphthoquinone. Breast Cancer Res 7: R19-R27, 2005.
34. Adachi S, Ito H, Tamamori-Adachi M, Ono Y, Nozato T, Abe S, Ikeda MA, Marumo F and Hiroe M: Cyclin A/cdk2 activation is involved in hypoxia-induced apoptosis in cardiomyocytes. Circ Res 88: 408-414, 2001.
35. Shrivastava A, Tiwari M, Sinha RA, Kumar A, Balapure AK., Bajpai VK, Sharma R, Mitra K, Tandon A and Godbole MM: Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving mitochondria-mediated pathway. J Biol Chem 281: 19762-19771, 2006.
36. Zhang JH, Zhang Y and Herman B: Caspase, apoptosis and aging. Ageing Res Rev 2: 357-366, 2003.
37. Oltvai ZN, Milliman S and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
38. Antonsson B, Montessuit S, Sanchez B and Martinou JC: Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 276: 11615-11623, 2001.
39. Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y and Kanakura Y: Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21 (WAF1/Cip1) by STAT5. Mol Cell Biol 17: 2933-2943, 1997.